BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36201713)

  • 1. Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes.
    Wu J; Ding V; Luo S; Choi E; Hellyer J; Myall N; Henry S; Wood D; Stehr H; Ji H; Nagpal S; Hayden Gephart M; Wakelee H; Neal J; Han SS
    JCO Precis Oncol; 2022 Oct; 6():e2200220. PubMed ID: 36201713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
    Kim M; Suh CH; Lee SM; Park JE; Kim HC; Kim SO; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    AJR Am J Roentgenol; 2021 Nov; 217(5):1184-1193. PubMed ID: 34037408
    [No Abstract]   [Full Text] [Related]  

  • 3. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
    Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
    Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
    Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
    Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
    Chen BT; Jin T; Ye N; Mambetsariev I; Daniel E; Wang T; Wong CW; Rockne RC; Colen R; Holodny AI; Sampath S; Salgia R
    Magn Reson Imaging; 2020 Jun; 69():49-56. PubMed ID: 32179095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy.
    Shen CI; Huang HC; Chiang CL; Luo YH; Shiao TH; Chiu CH
    Lung Cancer; 2019 Dec; 138():52-57. PubMed ID: 31634655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer.
    Na YC; Jung HH; Kim HR; Cho BC; Chang JW; Park YG; Chang WS
    J Neurooncol; 2017 Apr; 132(2):333-340. PubMed ID: 28074321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
    Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
    J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
    Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
    Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
    Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Silent brain metastasis in the initial staging of lung cancer: evaluation by computed tomography and magnetic resonance imaging].
    de Cos Escuín JS; Menna DM; González MA; Quirantes JZ; Vicente CD; Calvo MC
    Arch Bronconeumol; 2007 Jul; 43(7):386-91. PubMed ID: 17663891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance-based imaging biopsy with signatures including topological Betti number features for prediction of primary brain metastatic sites.
    Egashira M; Arimura H; Kobayashi K; Moriyama K; Kodama T; Tokuda T; Ninomiya K; Okamoto H; Igaki H
    Phys Eng Sci Med; 2023 Dec; 46(4):1411-1426. PubMed ID: 37603131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
    Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
    Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary?
    Farris MK; Wheless WH; Hughes RT; Soike MH; Masters AH; Helis CA; Chan MD; Cramer CK; Ruiz J; Lycan T; Petty WJ; Ahmed T; Leyrer CM; Blackstock AW
    Pract Radiat Oncol; 2019 Nov; 9(6):e599-e607. PubMed ID: 31271904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer.
    Digumarthy SR; Mendoza DP; Lin JJ; Chen T; Rooney MM; Chin E; Sequist LV; Lennerz JK; Gainor JF; Shaw AT
    Clin Lung Cancer; 2020 Mar; 21(2):153-159.e3. PubMed ID: 31708389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom.
    Jena A; Taneja S; Talwar V; Sharma JB
    J Thorac Oncol; 2008 Feb; 3(2):140-4. PubMed ID: 18303434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    Ozawa Y; Omae M; Fujii M; Matsui T; Kato M; Sagisaka S; Asada K; Karayama M; Shirai T; Yasuda K; Nakamura Y; Inui N; Yamada K; Yokomura K; Suda T
    BMC Cancer; 2015 Aug; 15():589. PubMed ID: 26275617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
    He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
    Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
    Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
    JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.